NCT05127460
Completed
Not Applicable
Computer-assisted Atrial Fibrillation Risk Detection In Oral-anticoagulant Use, Lowering Stroke Risk, and Optimizing Guidance With an Intelligent Screening Tool (CARDIOLOGIST): a Pragmatic Randomized Controlled Trial
National Defense Medical Center, Taiwan1 site in 1 country25,732 target enrollmentJanuary 1, 2022
ConditionsAtrial Fibrillation New Onset
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation New Onset
- Sponsor
- National Defense Medical Center, Taiwan
- Enrollment
- 25732
- Locations
- 1
- Primary Endpoint
- Proportion of taking AF treatment medications
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of Atrial Fibrillation.
Investigators
Chin Lin
Assistant Professor
National Defense Medical Center, Taiwan
Eligibility Criteria
Inclusion Criteria
- •Patients in emergency department or inpatient department
- •Patients had at least 1 ECG
- •Patients cared by non-cardiologist
Exclusion Criteria
- •Patients without history of atrial fibrillation diagnosis.
- •Patients without history of long-term NOAC or warfarin usage.
- •Patients without history of hemorrhagic stoke or ishemic stroke.
- •Patients with low eGFR (\<30 ml/min)
Outcomes
Primary Outcomes
Proportion of taking AF treatment medications
Time Frame: Within 90 days
defined as use of long-term NOAC (apixaban, rivaroxaban, endoxaban, dabigatran).
Proportion of ischemic Stroke
Time Frame: Within 90 days
After performing an electrocardiogram, the patient's physical conditions is tracked.
Secondary Outcomes
- Proportion of hemorrhagic stroke(Within 90 days)
- Proportion of all cause mortality(death)(Within 90 days)
- Proportion of cardiologist consultation(Within 90 days)
- Proportion of new-onset heart failure(Within 90 days)
- Proportion of new-onset AF diagnosis(Within 90 days)
- Proportion of echocardiogram performed after ECGs(Within 90 days)
- Proportion of gastrointestinal bleeding(Within 90 days)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
ECG AI-Guided Screening for Low Ejection FractionAsymptomatic Left Ventricular Systolic Dysfunction (Disorder)Heart FailureNCT04000087Mayo Clinic358
Completed
Not Applicable
Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using ElectrocardiogramsLeft Ventricular Systolic Dysfunction (Disorder)NCT05117970National Defense Medical Center, Taiwan13,631
Completed
Not Applicable
A Clinical Trial Screening for Atrial Fibrillation (AF-CATCH)Atrial FibrillationNCT02990741Shanghai Jiao Tong University School of Medicine4,348
Completed
Not Applicable
Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing MortalityCardiovascular DiseasesIntensity CareMoralityNCT05118035National Defense Medical Center, Taiwan15,965
Completed
Not Applicable
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.Atrial FibrillationNCT04045639Bristol-Myers Squibb260